AMERICAN INTERNATIONAL GROUP, INC. - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$711,743
-29.3%
44,373
+2.2%
0.01%
-16.7%
Q2 2023$1,006,476
-0.4%
43,420
-0.2%
0.01%
-14.3%
Q1 2023$1,010,737
+60.8%
43,510
+0.4%
0.01%
+75.0%
Q4 2022$628,704
-24.5%
43,329
-0.7%
0.00%
-33.3%
Q3 2022$833,000
+6.2%
43,643
+1.1%
0.01%
+20.0%
Q2 2022$784,000
-31.6%
43,148
-5.2%
0.01%
-16.7%
Q1 2022$1,146,000
-14.0%
45,492
-5.8%
0.01%
-14.3%
Q4 2021$1,333,000
-15.3%
48,282
-0.9%
0.01%
-12.5%
Q3 2021$1,573,000
+3.4%
48,711
-2.1%
0.01%
+60.0%
Q2 2021$1,522,000
+4.7%
49,755
+4.2%
0.01%0.0%
Q1 2021$1,454,000
+52.3%
47,741
-1.2%
0.01%
+25.0%
Q4 2020$955,000
+48.1%
48,315
-2.3%
0.00%
+33.3%
Q3 2020$645,000
+12.2%
49,467
-2.4%
0.00%0.0%
Q2 2020$575,000
-18.3%
50,673
+2.9%
0.00%
-25.0%
Q1 2020$704,000
-50.0%
49,231
-4.7%
0.00%
-20.0%
Q4 2019$1,407,000
-6.3%
51,664
-1.4%
0.01%
-16.7%
Q3 2019$1,501,000
+2.0%
52,418
-1.0%
0.01%0.0%
Q2 2019$1,471,000
-15.6%
52,959
+0.9%
0.01%
-14.3%
Q1 2019$1,743,000
+9.0%
52,486
-4.6%
0.01%0.0%
Q4 2018$1,599,000
-34.1%
54,995
+4.3%
0.01%
-12.5%
Q3 2018$2,426,000
+27.1%
52,744
+3.3%
0.01%
+14.3%
Q2 2018$1,908,000
+54.7%
51,060
+22.3%
0.01%
+75.0%
Q1 2018$1,233,000
-31.5%
41,741
-20.3%
0.00%
-33.3%
Q4 2017$1,799,000
-3.2%
52,394
+2.0%
0.01%
-14.3%
Q3 2017$1,859,000
+48.0%
51,379
+5.7%
0.01%
+75.0%
Q2 2017$1,256,000
+57.4%
48,602
+16.9%
0.00%
+33.3%
Q1 2017$798,000
+23.3%
41,571
+7.1%
0.00%
+50.0%
Q4 2016$647,000
-99.9%
38,824
-0.3%
0.00%
-33.3%
Q3 2016$801,077,000
-32.6%
38,925
+0.2%
0.00%
-40.0%
Q2 2016$1,189,300,000
-21.1%
38,866
-3.4%
0.01%
-16.7%
Q1 2016$1,507,000,000
-15.1%
40,248
-2.0%
0.01%
-14.3%
Q4 2015$1,774,000,000
+116075.5%
41,087
+0.8%
0.01%0.0%
Q3 2015$1,527,000
-99.9%
40,747
-0.1%
0.01%
+16.7%
Q2 2015$1,386,758,000
+2002.7%
40,799
+2090.0%
0.01%
Q1 2015$65,950,000
+3.3%
1,863
-0.6%
0.00%
Q4 2014$63,862,000
-61.2%
1,875
-56.0%
0.00%
-100.0%
Q3 2014$164,463,000
+22.1%
4,264
+23.2%
0.00%0.0%
Q2 2014$134,702,000
-4.5%
3,461
-16.1%
0.00%0.0%
Q1 2014$141,000,000
+422.2%
4,124
+220.4%
0.00%
Q4 2013$27,001,000
-54.5%
1,287
-49.0%
0.00%
Q3 2013$59,314,000
+48.6%
2,524
+69.9%
0.00%
Q2 2013$39,928,0001,4860.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders